(Q48374986)

English

Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine.

scientific article published on 16 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

1 reference

based on heuristic

inferred from title

Nicholas E Clifton

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

author name string

Nadège Morisot

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

Sylvie Girardon

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

Mark J Millan

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

Florence Loiseau

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

publication date

16 September 2012

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

number of pages

16

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

225

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

579-594

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

https://scigraph.springernature.com/pub.10.1007/s00213-012-2845-3

0 references

What does the amygdala contribute to social cognition?

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats--a possible model for schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Allosteric enhancement of metabotropic glutamate receptor 5 function promotes spatial memory.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Homer1a-dependent crosstalk between NMDA and metabotropic glutamate receptors in mouse neurons

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

The pathophysiology of fragile X (and what it teaches us about synapses)

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

U-shaped dose response in behavioral pharmacology: historical foundations

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

mGluR5 positive modulators both potentiate activation and restore inhibition in NMDA receptors by PKC dependent pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Regulation of phosphorylation of NMDA receptor NR1 subunits in the rat neostriatum by group I metabotropic glutamate receptors in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

MGlu5 antagonism impairs exploration and memory of spatial and non-spatial stimuli in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Translating developmental time across mammalian species.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Deficits in social cognition: a marker for psychiatric disorders?

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Mechanism-based approaches to treating fragile X

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Social discrimination procedure: an alternative method to investigate juvenile recognition abilities in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

The neuroendocrine basis of social recognition

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Cognitive neuroscience of self-regulation failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Negative symptoms and social cognition: identifying targets for psychological interventions

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activiti

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Neonatal phencyclidine treatment in mice induces behavioral, histological and neurochemical abnormalities in adulthood

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Metabotropic glutamate receptor 1 (mGluR1) and 5 (mGluR5) regulate late phases of LTP and LTD in the hippocampal CA1 region in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Metabotropic glutamate receptors: from the workbench to the bedside

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Metabotropic glutamate receptors: physiology, pharmacology, and disease

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Group I metabotropic glutamate receptors activate the p70S6 kinase via both mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK 1/2) signaling pathways in rat striatal and hippocampal synaptoneurosomes.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Effect of an NCAM mimetic peptide FGL on impairment in spatial learning and memory after neonatal phencyclidine treatment in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Metabotropic glutamate receptor subtype 5 antagonism in learning and memory

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Postnatal phencyclidine treatment differentially regulates N-methyl-D-aspartate receptor subunit mRNA expression in developing rat cerebral cortex.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Postnatal phencyclidine‐induced deficit in adult water maze performance is associated with N‐methyl‐d‐aspartate receptor upregulation

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Sustained brain-derived neurotrophic factor up-regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

The difference in effect of mGlu2/3 and mGlu5 receptor agonists on cognitive impairment induced by MK-801.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Activation of group I metabotropic glutamate receptors leads to brain-derived neurotrophic factor expression in rat C6 cells

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Gender and age at onset in schizophrenia: impact of family history

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2845-3

21 January 2018

Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of MPEP treatment on brain-derived neurotrophic factor gene expression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Task-dependent role for dorsal striatum metabotropic glutamate receptors in memory

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glutamatergic theories of schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-012-2845-3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22983144

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48374986&oldid=1786049913"